Home >> Tag Archives: Progenika Biopharma—

Tag Archives: Progenika Biopharma—

DNA-based blood compatibility test

March 2019—The FDA has approved ID Core XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell types. ID Core XT is the second molecular assay approved for use in transfusion medicine and the first to report genotypes as final results.  

Read More »